Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crescent Biopharma (CBIO) Treasury Shares (2016 - 2025)

Crescent Biopharma (CBIO) has disclosed Treasury Shares for 10 consecutive years, with $82129.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares changed N/A to $82129.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $82129.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $82129.0 for FY2025, N/A changed from the prior year.
  • Treasury Shares for Q4 2025 was $82129.0 at Crescent Biopharma, down from $438386.0 in the prior quarter.
  • The five-year high for Treasury Shares was $590654.0 in Q2 2021, with the low at $48133.0 in Q3 2024.
  • Average Treasury Shares over 5 years is $243666.3, with a median of $205094.0 recorded in 2022.
  • The sharpest move saw Treasury Shares plummeted 63.43% in 2022, then surged 810.78% in 2025.
  • Over 5 years, Treasury Shares stood at $345600.0 in 2021, then crashed by 40.75% to $204785.0 in 2022, then plummeted by 42.79% to $117157.0 in 2023, then crashed by 58.92% to $48133.0 in 2024, then soared by 70.63% to $82129.0 in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $82129.0, $438386.0, and $438386.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.